Safety and pharmacokinetics of dicloxacillin in healthy Chinese volunteers following single and multiple oral doses.

DRUG DESIGN DEVELOPMENT AND THERAPY(2015)

引用 4|浏览11
暂无评分
摘要
Background: Dicloxacillin, a semisynthetic isoxazolyl penicillin antibiotic, has antimicrobial activity against a wide variety of gram-positive bacteria including Staphylococcus aureus, Streptococcus pyogenes, Streptococcus pneumonia, Streptococcus epidermidis, Streptococcus viridans, Streptococcus agalactiae, and Neisseria meningitidis. The objective of this study was to evaluate the safety and pharmacokinetic profile of dicloxacillin after single and multiple oral dose in healthy Chinese volunteers. Methods: A single-center, open-label, randomized, two-phase study was conducted in 16 subjects. In the single-dose phase, subjects were randomly assigned to receive single doses of 0.25, 0.5, 1.0, and 2.0 g of dicloxacillin sodium capsule in a 4-way crossover design with a 5-day washout period between administrations. In the multiple-dose phase, subjects were assigned to receive 0.25 or 0.5 g every 6 hours for 3 days in a 2-way crossover design. Plasma and urine pharmacokinetic samples were assayed by a validated high-performance liquid chromatographytandem mass spectrometry method. Pharmacokinetic parameters were calculated and analyzed statistically. Safety assessments were conducted throughout the study. Results: Following a single oral dose of 0.25-2.0 g dicloxacillin sodium, the maximum plasma drug concentration (C-max) and the corresponding values for the area under the concentration-time curve from 0 to 10 hours (AUC(0-10) h) increased in a dose-proportional manner. The mean elimination half-life (t(1/2)) was in the range of 1.38-1.71 hours. Dicloxacillin was excreted in its unchanged form via the kidney, with no tendency of accumulation, and varied from 38.65% to 50.10%. No appreciable accumulation of drug occurred with multiple oral doses of dicloxacillin. No serious adverse events were reported. Adverse events were generally mild. Conclusion: Dicloxacillin was safe and well tolerated in the volunteers and displayed linear increases in the C-max and AUC(0-10) h values.
更多
查看译文
关键词
dicloxacillin,safety,tolerability,pharmacokinetics,healthy volunteers
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要